157 related articles for article (PubMed ID: 36437410)
21. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 2001 May; 8(4):278-89. PubMed ID: 11352300
[TBL] [Abstract][Full Text] [Related]
22. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
23. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
24. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
25. Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients.
Rööser B; Willén H; Gustafson P; Alvegård TA; Rydholm A
Cancer; 1991 Jan; 67(2):499-505. PubMed ID: 1845950
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].
Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395
[No Abstract] [Full Text] [Related]
29. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
30. Myxofibrosarcoma: Clinical and Prognostic Value of MRI Features.
Spinnato P; Sambri A; Fujiwara T; Ceccarelli L; Clinca R; Medellin MR; Paolis M; Donati DM; Bianchi G
Curr Med Imaging; 2021; 17(2):217-224. PubMed ID: 32729425
[TBL] [Abstract][Full Text] [Related]
31. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
32. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of therapeutic strategies and prognostic factors of malignant fibrous histiocytoma of soft tissue].
Li GX; Guo W
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):974-7. PubMed ID: 22333415
[TBL] [Abstract][Full Text] [Related]
34. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities.
Vasileios KA; Eward WC; Brigman BE
Arch Orthop Trauma Surg; 2012 Jul; 132(7):955-61. PubMed ID: 22487849
[TBL] [Abstract][Full Text] [Related]
36. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
[TBL] [Abstract][Full Text] [Related]
37. The incidence of unplanned excision in patients with soft tissue sarcoma: Reports from the Bone and Soft Tissue Tumor registry in Japan.
Nakamura T; Kawai A; Sudo A
J Orthop Sci; 2022 Mar; 27(2):468-472. PubMed ID: 33558102
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
39. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
40. Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ; Bernard SA
Skeletal Radiol; 2023 Mar; 52(3):435-445. PubMed ID: 35867123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
